SUBSCRIPTION AGREEMENTSubscription Agreement • May 29th, 2020 • Fisher Wallace Laboratories, Inc. • New York
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES, AND NO PUBLIC MARKET IS EXPECTED TO DEVELOP FOLLOWING THIS OFFERING.
POSTING AGREEMENTPosting Agreement • January 17th, 2023 • Fisher Wallace Laboratories, Inc. • Surgical & medical instruments & apparatus • California
[Fisher Wallace Laboratories, Inc.][COMPANY], a [Delaware][STATE] [C-Corp][ENTITY] located at [630 Flushing Avenue, Brooklyn, NY][ADDRESS] (the “Company”), proposes, subject to the terms and conditions contained in this Posting Agreement (this “Agreement”), to issue and sell shares of its [Class B Common Stock] [SECURITIES], $XXX par value per share (the “Shares”) to investors (collectively, the “Investors”) in a public offering (the “Offering”) on the online website provided by StartEngine Crowdfunding, Inc. (the “Platform”) pursuant to Regulation A through StartEngine Primary LLC ( “StartEngine”), acting on a best efforts basis only, in connection with such sales. The Shares are more fully described in the Offering Statement (as hereinafter defined).
Escrow Agreement FOR SECURITIES OFFERINGEscrow Agreement • January 17th, 2023 • Fisher Wallace Laboratories, Inc. • Surgical & medical instruments & apparatus • Delaware
This Escrow Agreement, effective as of _____________, (“Escrow Agreement”), is by, between and among The Bryn Mawr Trust Company of Delaware, a Delaware Limited Purpose Trust Company and located at 20 Montchanin Rd., Suite 100, Greenville, DE 19807 as Escrow Agent hereunder (“Escrow Agent”); StartEngine Primary LLC (“Broker”), a Delaware Limited Liability Company, located at 3900 W. Alameda Ave, Burbank, CA 91505 ; and ____________________________, a __________________________ (“Issuer”) located at ___________________________________________________________________.
POSTING AGREEMENTPosting Agreement • May 29th, 2020 • Fisher Wallace Laboratories, Inc. • California
[Fisher Wallace Laboratorie][COMPANY], a [Delaware][STATE] [Corporation][ENTITY] located at [515 Madison Avenue, NY, NY][ADDRESS] (the “Company”), proposes, subject to the terms and conditions contained in this Posting Agreement (this “Agreement”), to issue and sell shares of its [Class B][SECURITIES], $XXX par value per share (the “Shares”) to investors (collectively, the “Investors”) in a public offering (the “Offering”) on the online website provided by StartEngine Crowdfunding, Inc. (the “Platform”) pursuant to Regulation A through StartEngine Primary LLC (“StartEngine”), acting on a best efforts basis only, in connection with such sales. The Shares are more fully described in the Offering Statement (as hereinafter defined).
StartEngine Secure Service AgreementStartengine Secure Service Agreement • May 29th, 2020 • Fisher Wallace Laboratories, Inc. • California
This agreement (“Agreement”) sets forth the terms and conditions by which Fisher Wallace Laboratories Inc (“Issuer”, “you”, “your”) appoints StartEngine Secure LLC (“Service Provider”, “us”, “our”, “we”) as the exclusive provider of software and services relating to the recording of the issuance, transfer and registration of Issuer’s securities issued pursuant to Regulation A, and associated holder positions, and for clearing ownership changes and new issuances (the “Services”) of the Issuer’s Reg A securities (the “Securities”). The parties hereby agree to the following Terms and Conditions:
ContractQuotation Agreement • February 23rd, 2021 • Fisher Wallace Laboratories, Inc. • Surgical & medical instruments & apparatus • California
THIS QUOTATION AGREEMENT, dated as of the date executed by StartEngine Primary, LLC, a Delaware limited liability company (“Primary”), with an office at 3900 W Alameda Ave, Suite 1200, Burbank, CA 91505, is by and between Primary and the Company, as identified below (the “Company”).
FORM OF SUBSCRIPTION AGREEMENTSubscription Agreement • January 17th, 2023 • Fisher Wallace Laboratories, Inc. • Surgical & medical instruments & apparatus • New York
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES, AND NO PUBLIC MARKET IS EXPECTED TO DEVELOP FOLLOWING THIS OFFERING.
FORM OF SUBSCRIPTION AGREEMENTSubscription Agreement • February 21st, 2023 • Fisher Wallace Laboratories, Inc. • Surgical & medical instruments & apparatus • New York
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES, AND NO PUBLIC MARKET IS EXPECTED TO DEVELOP FOLLOWING THIS OFFERING.
Explanatory NoteFisher Wallace Laboratories, Inc. • August 10th, 2020 • Surgical & medical instruments & apparatus
CREDIT CARD SERVICES AGREEMENTServices Agreement • May 29th, 2020 • Fisher Wallace Laboratories, Inc.
This Services Agreement (“Services Agreement” or “Agreement”) is entered into as of the date noted below (the “Effective Date”) between StartEngine Crowdfunding, Inc., a Delaware corporation (“Company”), and Fisher Wallace Laboratories a Delaware corporation (“Customer” or “you”).
EXHIBITSFisher Wallace Laboratories, Inc. • February 17th, 2023 • Surgical & medical instruments & apparatus
